Skip to content

Effect of Blue Light Glasses on Screen Usage After a Concussion in College Students

Effect of Blue Light Glasses on Screen Usage After a Concussion in College Students

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04804501
Enrollment
64
Registered
2021-03-18
Start date
2021-03-01
Completion date
2022-12-31
Last updated
2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Concussion

Brief summary

Premature cessation of screen usage is a common behavior post-concussion, given the taxing nature of a screen-time task. In the academic setting, screen-time is a near unavoidable component, however, complete avoidance of class and screen use may in fact provoke psychological symptoms of anxiety and depression in students, for fear of falling behind in their studies. Thus, compensatory measures should be investigated to assist students as they attempt to maintain academic involvement throughout their concussion recovery. Blue light blocking glasses have been shown to significantly increase screen-time usage in individuals with post-concussion syndrome, yet these results are only representative of a small portion of the concussion population. Thus, we propose investigating whether blue light blocking glasses can prolong screen usage prior to symptom exacerbation, specifically in concussed students that are still within the normal recovery timeframe. This cross-sectional randomized clinical trial will provide further evidence of the utility blue light blocking glasses can offer as a therapeutic tool for students recovering from concussion. We would like to test volunteers from the Rochester Institute of Technology who have been treated by a medical provider within the university's health center. Blue light glasses will be worn during a one-time computer reading task while the subject is participating in the study. The total time for the complete the reading task is dependent upon the participant's symptom fluctuations; however, we suspect completion criteria will be met within 20 minutes from beginning. The risks in this study are minimal and results may increase our understanding of therapeutic tools for patients with ocular-driven concussion symptoms.

Interventions

DEVICEBlue Light Glasses

Participants will be randomized into an experimental group (blue light glasses) or a control group (no glasses). Participants will perform a computer reading task while either wearing, or not wearing the glasses.

OTHERComputer Reading Task

Participants will read on a computer until concussion symptoms increase by a score of 3 or more (reading task termination criteria). One or more points will be assigned for each increase in symptom severity, and one point will be assigned for each new symptom that appears.

Sponsors

Rochester Institute of Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 26 Years
Healthy volunteers
No

Inclusion criteria

* Full-time student at RIT * Diagnosed mild traumatic brain injury * Between 18-26 years of age * Within 3-14 days post-injury

Exclusion criteria

* Any head, neck, or face injury in the 1 year prior to the study (e.g., concussion, eye injury) other than the current injury * History of vestibular or ocular dysfunction\\ * Any neurological disorders (e.g., seizure disorders, closed head injuries with loss of consciousness greater than 15 minutes, CNS neoplasm, history of stroke) * Injury more severe than mild traumatic brain injury (skull fracture, positive CT or MRI) * Having taken pain medication within 8 hours prior to testing * Not able to personally consent * Pregnant * Deaf or hard of hearing.

Design outcomes

Primary

MeasureTime frameDescription
Time on Screen30 minutes or lessThe amount of time a participant can spend on time, prior to meeting termination criteria, will be recorded and compared between experimental and control groups.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026